ABT Jan 2026 80.000 call
- Investor's Business Daily
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Abbott Laboratories gained U.S. clearance Monday for a pair of new CGMs. But Abbott stock fell a fraction at the close.
- PR Newswire
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology1, now used by about 6 million people globally2. The newly cleared systems have been intentionally designed to meet different needs – Lingo for consumers who want to better understand and improve their health and welln
- Insider Monkey
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
We recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since Abbott Laboratories (NYSE:ABT) ranks higher on our list, we have analyzed the stock in detail. The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm. Between these two, dividend growth is currently […]
